Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients

INTRODUCTION: The soluble receptor of urokinase plasminogen activator (suPAR) is an innate immunity/inflammation biomarker predicting cardiovascular (CV) and non-CV events in various conditions, including type 2 diabetic patients on dialysis. However, the relationship between suPAR and clinical outc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Torino, Claudia, Pizzini, Patrizia, Cutrupi, Sebastiano, Postorino, Maurizio, Tripepi, Giovanni, Mallamaci, Francesca, Reiser, Jochen, Zoccali, Carmine
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6127402/
https://ncbi.nlm.nih.gov/pubmed/30197976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.05.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados